Omeprazole, a widely used proton pump inhibitor (PPI), is essential for treating acid reflux, ulcers, and other gastrointestinal disorders. As a high-demand pharmaceutical compound, its price is influenced by raw material costs, API production capacities, regulatory landscapes, and global demand-supply dynamics. The second quarter of 2025 witnessed significant developments across regions that shaped the pricing structure of omeprazole.
Omeprazole Price Trend Analysis – Q2 2025
Asia-Pacific (India, China):
In Q2, omeprazole prices in Asia displayed mild fluctuations. India, a key hub for API production, saw stable pricing due to balanced domestic demand and export orders. However, temporary disruptions in the supply of key intermediates in China slightly inflated production costs, resulting in marginal price increases.
- India FOB Price (April–June 2025): Ranged between USD 75–85/kg depending on purity and volume.
- China Domestic Price: Showed a 2–3% quarterly uptick, mainly due to raw material costs.
Europe:
The European market experienced a slight price drop, largely due to oversupply and sluggish demand from generic drug manufacturers. However, strict compliance regulations and GMP requirements continue to keep production costs high, maintaining a price floor.